We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand.
- Authors
Deerochanawong, Chaicharn; Krittayaphong, Rungroj; Romano, Jack Garcia Uranga; Rhee, Nicolai A.; Permsuwan, Unchalee
- Abstract
CV cardiovascular, ICER incremental cost-effectiveness ratio, MI myocardial infarction, QALY quality-adjusted life-year, RRT renal replacement therapy, SoC standard of care, THB Thai baht The Fig. CV cardiovascular, ICER incremental cost-effectiveness ratio, MI myocardial infarction, QALY quality-adjusted life-year, RRT renal replacement therapy, SoC standard of care, THB Thai baht The original article has been updated. CV cardiovascular, ICER incremental cost-effectiveness ratio, MI myocardial infarction, QALY quality-adjusted life-year, RRT renal replacement therapy, SoC standard of care, THB Thai baht The updated Fig.
- Subjects
THAILAND; TYPE 2 diabetes; CARDIOVASCULAR diseases risk factors; CARE of people; LIRAGLUTIDE
- Publication
Diabetes Therapy, 2023, Vol 14, Issue 5, p947
- ISSN
1869-6953
- Publication type
Correction Notice
- DOI
10.1007/s13300-023-01392-7